Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) Rosetta Genomics stock is having a rough day in the market today. However, it actually doesn't look all that bad in my opinion. The reality is that we saw massive gains yesterday, and the …
Before investing one should read a report on Rosetta Genomics stock analysis. It helps to look at the following income statement items: Revenue: The money received by selling of goods or services comes under this line item. A QoQ …
Rosetta Genomics (ROSG) stock surged on Friday after Cantor Fitzgerald initiated coverage on the stock with a 'speculative buy' rating. Rosseta Genomics (ROSG) shares are climbing after analysts at Cantor upgraded the stock to …
(To watch Kolbert’s track record, click here) In reaction to the analyst’s bullish …
Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, announces the effectiveness of a 1-for-12 reverse …
Stock market analysts watching Rosetta Genomics Ltd. (ROSG) have recently changed their ratings on the stock. The latest reports which are outstanding on Wednesday 17th of May state 0 analysts have a rating of “strong buy”, 2 …
Rosetta Genomics (NASDAQ:ROSG) is a stock that has been beaten up in the last few years. The price has gone from $300 in 2008 to a mere 4$ in 2012. This has been a result of a reverse stock split and numerous shares being issued in …
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, …
Rosetta Genomics, Ltd. (NASDAQ: ROSG) announced the effectiveness of a one-for-four reverse stock split of its share capital. The reverse stock split, which was previously approved by the Company's Board of Directors, was approved by …
ROSETTA GENOMICS ANNOUNCES 1-FOR-12 REVERSE STOCK SPLIT Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on March 17, 2017 PHILADELPHIA and REHOVOT, Israel (March 16, 2017) - Rosetta Genomics Ltd. …